Read more about what we do!

The ambition of OSIRIS  is to reform the R&I (Research and Innovation) system such that reproducibility is more accepted, practised, and recognized within the global scientific practice by 2026 (i.e, ~30% of all EU researchers and ~50% of all other stakeholders such as funders and publishers). The project will develop and test effective, evidence-based solutions for the reproducibility crisis across various stakeholders in policy and research practice, embed reproducibility in the strategy and design of research projects, and create a collaborative community of stakeholders that will aid in educating and implementing better reproducible research practices.

Project title: OSIRIS (Open Science to Increase Reproducibility In Science)

The role of CZU in the project: Our role is especially in the leadership of WP6: Dissemination and Communication together with YPARD EUROPE. Furthermore, our role is in the cross-sectional activities, such as Interventions to improve reproducibility for funders and journals, Interventions to improve reproducibility for researchers and institutes, Training and guidance.

Our team: Assoc. Prof. Dr. Hynek Roubík, Dr. Stacy Denise Hammond Hammond, Ing. Jan Staš

Team lead: Assoc. Prof. Dr. Hynek Roubík (leader), Dr. Stacy Denise Hammond Hammond (co-leader)

Time period: 2023-2026 (48 months)

Project budget: 2M EUR

CZU budget: 225,375 EUR

Consortium: OSIRIS is composed of an interdisciplinary consortium of members from 10 institutions in 7 different European countries. University Medical Centre Utrecht (UMCU) - NL, Academic Medical Centre (AMC)- NL, KU Leuven (KUL) - BE, Mario Negri Institute for Pharmacological Research (IRFMN) - IT, Hungarian University of Agriculture and Life Science (MATE) - HU, Czech University of Life Sciences (CZU) - CZ, Young professionals for agricultural development (YPARD) - CZ, National Institute of Health and Medical Research (Inserm): Organization for ethical and responsible Inserm research (INSERM) - FR, University of Oxford (UOXF) / AllTrials - UK, Sense about science (SAS)- UK.

OSIRIS Team: The consortium consists of coordinator UMCU (led by Dr. Inge Stegeman), the front-running Dutch university on Open Science, and a pan-European group of research entities and outreach organisations. OSIRIS's strength lies in uniting researchers that have a unique Open Science (OS) focus (e.g. vice-coordinator Dr. Van den Eynden, KUL) and methods researchers (e.g. Dr. Mariska Leeflang, AMC and prof. Ravaud, INSERM) and researchers that practice OS in their own research, such as Assoc. Prof. Dr. Hynek Roubík (CZU).

Call: HORIZON-WIDERA-2022-ERA-01-41 — Increasing the reproducibility of scientific results

Další články v rubrice

English ☰ Menu
Cookie settings

We use cookies and similar technologies on the websites of the Czech University of Life Sciences Prague (under the domain czu.cz) to ensure the proper functioning of the website. With your consent, we also use them to measure traffic (Google Analytics 4), analyze website performance, and for marketing purposes (Meta, Sklik, Google Ads), including displaying embedded videos (YouTube). Information about how you use our websites may be shared with our partners in the fields of analytics, social media, and online advertising. Essential cookies are always active. You can change or revoke your cookie preferences and consent at any time in "Cookie Settings."